GRM5 and Parkinson disease: Increased levels of the metabotropic glutamate receptor mGluR5 have been observed in the hippocampus and basal ganglia of a transgenic (Tg) mouse model of PD, indicating that α-synuclein may directly interact with mGluR5 to cause overactivation of this receptor, leading to excitotoxic cell death [17].